Sun Pharmaceutical Industries is currently trading at Rs. 600.50, up by 10.40 points or 1.76% from its previous closing of Rs. 590.10 on the BSE.
The scrip opened at Rs. 597.00 and has touched a high and low of Rs. 608.10 and Rs. 591.65 respectively. So far 196338 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 627.95 on 11-Jan-2021 and a 52 week low of Rs. 315.20 on 23-Mar-2020.
Last one week high and low of the scrip stood at Rs. 599.90 and Rs. 550.70 respectively. The current market cap of the company is Rs. 145831.58 crore.
The promoters holding in the company stood at 54.48%, while Institutions and Non-Institutions held 33.03% and 12.49% respectively.
Sun Pharmaceutical Industries has reported 18.51% rise in its net profit of Rs 555.55 crore for third quarter ended December 31, 2020 as compared to net profit of Rs 468.76 crore for the same quarter in the previous year. Total income of the company increased by 12.55% at Rs 3409.00 crore for Q3FY21 as compared Rs 3028.91 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported 2- fold jump in its net profit after taxes, share of profit of associates and joint ventures and non-controlling interests at Rs 1852.48 crore for third quarter ended December 31, 2020 as compared to net profit at Rs 913.52 crore for the same quarter in the previous year. Total income of the company increased by 10.60% at Rs 9151.73 crore for Q3FY21 as compared Rs 8274.73 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1786.05 |
Dr. Reddys Lab | 1354.20 |
Cipla | 1470.05 |
Lupin | 2190.50 |
Zydus Lifesciences | 1004.05 |
View more.. |